305 related articles for article (PubMed ID: 28608996)
21. General and cancer mortality in a large cohort of Italian alcoholics.
Saieva C; Bardazzi G; Masala G; Quartini A; Ceroti M; Iozzi A; Gelain E; Querci A; Allamani A; Palli D
Alcohol Clin Exp Res; 2012 Feb; 36(2):342-50. PubMed ID: 22085221
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma.
Tracy SI; Maurer MJ; Witzig TE; Drake MT; Ansell SM; Nowakowski GS; Thompson CA; Inwards DJ; Johnston PB; Micallef IN; Allmer C; Macon WR; Weiner GJ; Slager SL; Habermann TM; Link BK; Cerhan JR
Blood Cancer J; 2017 Aug; 7(8):e595. PubMed ID: 28841207
[TBL] [Abstract][Full Text] [Related]
23. Noncancer causes of death in survivors of testicular cancer.
Fosså SD; Gilbert E; Dores GM; Chen J; McGlynn KA; Schonfeld S; Storm H; Hall P; Holowaty E; Andersen A; Joensuu H; Andersson M; Kaijser M; Gospodarowicz M; Cohen R; Pukkala E; Travis LB
J Natl Cancer Inst; 2007 Apr; 99(7):533-44. PubMed ID: 17405998
[TBL] [Abstract][Full Text] [Related]
24. Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
Ruella M; Filippi AR; Bruna R; Di Russo A; Magni M; Caracciolo D; Passera R; Matteucci P; Di Nicola M; Corradini P; Parvis G; Gini G; Olivieri A; Ladetto M; Ricardi U; Tarella C; Devizzi L
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):783-91. PubMed ID: 26972651
[TBL] [Abstract][Full Text] [Related]
25. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
Evens AM; Vanderplas A; LaCasce AS; Crosby AL; Nademanee AP; Kaminski MS; Abel GA; Millenson M; Czuczman MS; Rodriguez MA; Niland J; Zelenetz AD; Gordon LI; Friedberg JW
Cancer; 2013 Oct; 119(20):3662-71. PubMed ID: 23921646
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
27. Life expectancy of young adults with follicular lymphoma.
Conconi A; Lobetti-Bodoni C; Montoto S; Lopez-Guillermo A; Coutinho R; Matthews J; Franceschetti S; Bertoni F; Moccia A; Rancoita PM; Gribben J; Cavalli F; Gaidano G; Lister TA; Montserrat E; Ghielmini M; Zucca E
Ann Oncol; 2015 Nov; 26(11):2317-22. PubMed ID: 26362567
[TBL] [Abstract][Full Text] [Related]
28. Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population.
Magnano L; Alonso-Alvarez S; Alcoceba M; Rivas-Delgado A; Muntañola A; Nadeu F; Setoain X; Rodríguez S; Andrade-Campos M; Espinosa-Lara N; Rodríguez G; Sancho JM; Moreno M; Mercadal S; Carro I; Salar A; Garcia-Pallarols F; Arranz R; Cannata J; Terol MJ; Teruel AI; Jiménez-Ubieto A; Rodriguez A; González de Villambrosía S; Bello JL; López L; Novelli S; de Cabo E; Infante ME; Pardal E; Monsalvo S; González M; Martín A; Caballero MD; López-Guillermo A;
Br J Haematol; 2019 May; 185(3):480-491. PubMed ID: 30793290
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults.
Gangatharan SA; Maganti M; Kuruvilla JG; Kukreti V; Tiedemann RE; Gospodarowicz MK; Hodgson DC; Sun A; Tsang RW; Pintilie M; Crump M
Br J Haematol; 2015 Aug; 170(3):384-90. PubMed ID: 25904266
[TBL] [Abstract][Full Text] [Related]
30. The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas.
Tracy SI; Larson MC; Feldman AL; Maurer MJ; Novak AJ; Slager SL; Villasboas JC; Allmer C; Habermann TM; Farooq U; Syrbu S; Cerhan JR; Link BK
Am J Hematol; 2019 Jun; 94(6):658-666. PubMed ID: 30916801
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.
Guadagnolo BA; Li S; Neuberg D; Ng A; Hua L; Silver B; Stevenson MA; Mauch P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):928-34. PubMed ID: 16243446
[TBL] [Abstract][Full Text] [Related]
32. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
[TBL] [Abstract][Full Text] [Related]
33. Pros and cons of rituximab maintenance in follicular lymphoma.
Zhang L; Ghielmini M; Cheson BD; Ujjani C
Cancer Treat Rev; 2017 Jul; 58():34-40. PubMed ID: 28628883
[TBL] [Abstract][Full Text] [Related]
34. Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network study.
Rajguru S; Kristinsdottir T; Eickhoff J; Peterson C; Meyer CM; Traynor AM; Kahl BS
Clin Adv Hematol Oncol; 2014 Aug; 12(8):509-15. PubMed ID: 25356575
[TBL] [Abstract][Full Text] [Related]
35. Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.
Herold M; Haas A; Srock S; Neser S; Al-Ali KH; Neubauer A; Dölken G; Naumann R; Knauf W; Freund M; Rohrberg R; Höffken K; Franke A; Ittel T; Kettner E; Haak U; Mey U; Klinkenstein C; Assmann M; von Grünhagen U;
J Clin Oncol; 2007 May; 25(15):1986-92. PubMed ID: 17420513
[TBL] [Abstract][Full Text] [Related]
36. Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.
Nabhan C; Byrtek M; Rai A; Dawson K; Zhou X; Link BK; Friedberg JW; Zelenetz AD; Maurer MJ; Cerhan JR; Flowers CR
Br J Haematol; 2015 Jul; 170(1):85-95. PubMed ID: 25851937
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.
Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ
Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595
[TBL] [Abstract][Full Text] [Related]
38. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
[TBL] [Abstract][Full Text] [Related]
39. Causes of death in patients with celiac disease in a population-based Swedish cohort.
Peters U; Askling J; Gridley G; Ekbom A; Linet M
Arch Intern Med; 2003 Jul; 163(13):1566-72. PubMed ID: 12860579
[TBL] [Abstract][Full Text] [Related]
40. Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases.
Boyle T; Connors JM; Gascoyne RD; Berry BR; Sehn LH; Bashash M; Spinelli JJ
Br J Haematol; 2017 Aug; 178(3):442-447. PubMed ID: 28466570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]